ACTIVE

BRUSSELS REPS PHARMA

Financial year 2025 · Closed on 31/12/2025

Net result
349,9 k €
+85,7 %over 1 year
Revenue
4,2 M €
+12,8 %over 1 year
Equity
2,3 M €
-0,0 %over 1 year
Workforce
31,7 ETP
-8,9 %over 1 year

Identity

Source · BCE/KBO

BRUSSELS REPS PHARMA is a Private limited company incorporated in 2003. Its main activity is: Agents involved in the sale of furniture, household goods, hardware and ironmongery. Its registered office is in Anderlecht. It employs on average 31,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0480.073.487
Incorporation
24/04/2003
Legal form
Private limited company
Registered office
Rue Ile Ste Hélène 5
1070 Anderlecht · BruxellesSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
31,7 ETP
Joint committees (1)
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Revenue4,2 M €3,7 M €4,1 M €3,4 M €3,5 M €
EBITDA604,4 k €269,4 k €547,4 k €141,2 k €-61,7 k €
Operating result599,3 k €269,4 k €545,2 k €135,9 k €-73 k €
Net result349,9 k €188,4 k €245,6 k €-129,8 k €-110 k €
Balance sheet
Equity2,3 M €2,3 M €2,1 M €1,9 M €2,1 M €
Total assets3,3 M €3 M €3 M €2,6 M €5 M €
Cash765,1 k €2,1 M €640,7 k €1,8 M €3,9 M €
Debts978 k €699,9 k €850,3 k €717,7 k €2,8 M €
Other
Workforce31,7 ETP34,8 ETP36,7 ETP34,9 ETP42,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 12 ended

Active mandates

URSZULA KWIATKOWSKA

Mandate

Active

Ended mandates

FRANCOIS BAUDIER

Managing director · since 01 juillet 2015 · until 30 juin 2021

Ended
JACQUELINE MARECHAL

Director · since 01 janvier 2014 · until 31 décembre 2019

Ended
NORBERT VAN MUYLEM

Managing director · since 01 janvier 2014 · until 21 mai 2015

Ended
NORBERT VAN MUYLEM

Managing director · since 01 janvier 2014 · until 31 décembre 2019

Ended

Other companies at this address

Rue Ile Ste Hélène 5 1070 Anderlecht
CompanyCBE no.
MT-SERVICEActive
0884.198.055
StimacJudicial reorganisation
0406.136.327

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date30/06/202619/12/202504/11/202428/07/202305/10/202203/12/2021
General meeting12/06/202612/06/202516/05/202412/06/202318/05/202220/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202512/06/202630/06/2026FrenchPDF
Abridged model31/12/202412/06/202519/12/2025FrenchPDF
Abridged model31/12/202316/05/202404/11/2024FrenchPDF
Abridged model31/12/202212/06/202328/07/2023FrenchPDF
Abridged model31/12/202118/05/202205/10/2022FrenchPDF
Abridged model31/12/202020/05/202103/12/2021FrenchPDF
Abridged model31/12/201914/05/202013/01/2021FrenchPDF
Abridged model31/12/201816/05/201915/07/2019FrenchPDF
Abridged model31/12/201717/05/201819/11/2018FrenchPDF
Abridged model31/12/201618/05/201723/08/2017FrenchPDF
Abridged model31/12/201519/05/201614/12/2016FrenchPDF
Abridged model31/12/201421/05/201523/09/2015FrenchPDF
Abridged model31/12/201315/05/201405/12/2014FrenchPDF
Abridged model31/12/201216/05/201313/08/2013FrenchPDF
Abridged model31/12/201117/05/201218/07/2012FrenchPDF
Abridged model31/12/201019/05/201113/07/2011FrenchPDF
Abridged model31/12/200920/05/201029/07/2010FrenchPDF
Abridged model31/12/200821/05/200930/06/2009FrenchPDF
Abridged model31/12/200722/05/200830/06/2008FrenchPDF
Abridged model31/12/200619/05/200706/07/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 12 ended

Active mandates

URSZULA KWIATKOWSKA

Mandate

Active

Ended mandates

FRANCOIS BAUDIER

Managing director · since 01 juillet 2015 · until 30 juin 2021

Ended
JACQUELINE MARECHAL

Director · since 01 janvier 2014 · until 31 décembre 2019

Ended
NORBERT VAN MUYLEM

Managing director · since 01 janvier 2014 · until 21 mai 2015

Ended
NORBERT VAN MUYLEM

Managing director · since 01 janvier 2014 · until 31 décembre 2019

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates28/12/2022
    DENOMINATION - DEMISSIONS, NOMINATIONS - MODIFICATION FORME JURIDIQUE
    PDF
  • Mandates11/02/2022
    DEMISSIONS, NOMINATIONS
    PDF
  • Registered office02/08/2021
    SIEGE SOCIAL
    PDF
  • Registered office15/07/2020
    SIEGE SOCIAL
    PDF
  • Mandates18/03/2020
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates07/08/2015
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates06/01/2014
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates18/04/2013
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025349,9 k €
  2. 2024
    Annual accounts 2024188,4 k €
  3. 2023
    Annual accounts 2023245,6 k €
  4. 2022
    Annual accounts 2022-129,8 k €
  5. 2022
    Name changeBRUSSELS REPS PHARMA
  6. 2021
    Annual accounts 2021-110 k €
  7. 2021
    Name changeSMB PHARMA
  8. 2020
    Annual accounts 2020-385 k €
  9. 2019
    Annual accounts 2019933,8 k €
  10. 2018
    Annual accounts 2018581 k €
  11. 2017
    Annual accounts 2017610,6 k €
  12. 2016
    Annual accounts 2016544,1 k €
  13. 2015
    Annual accounts 2015479,7 k €
  14. 2014
    Annual accounts 2014372,1 k €
  15. 2013
    Annual accounts 2013475,4 k €
  16. 2012
    Annual accounts 2012121,1 k €
  17. 2011
    Annual accounts 2011-7,7 k €
  18. 2010
    Annual accounts 201016 k €
  19. 2009
    Annual accounts 2009344,2 k €
  20. 2008
    Annual accounts 200829,4 k €
  21. 2007
    Annual accounts 200751,1 k €
  22. 24/04/2003
    IncorporationPrivate limited company